Skip to search.
 FTSE 100 Down 0.67%

Alkermes plc (ALKS)

-NasdaqGS
63.07 Down 1.70(2.62%) 2 Jul 21:00
Add to Portfolio
Prev Close:64.77
Open:64.88
Bid:58.11 x 100
Ask:69.99 x 100
1y Target Est:70.82
Beta:1.31
Earnings Date:27 Jul - 31 Jul (Est.)
Day's Range:62.89 - 64.88
52wk Range:38.49 - 75.17
Volume:1,107,236
Avg Vol (3m):1,117,490
Market Cap:9.37b
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSDown 2.62%9.37b
ABTDown 0.22%73.56b
LLYUp 1.52%91.22b
GSKUp 0.28%102.06b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.44
Quarterly EPS Est (Jun-15) :-0.08
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-4.27

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback